*ST宁科关于控股股东股份被第二次司法拍卖的进展公告
Filed with SSE ·
On 6ix: 6ix.com/news/st
6ix hasn’t read this filing yet.
Ningxia Zhongke Biotechnology Co., Ltd. on 6ix
Earlier from Ningxia Zhongke Biotechnology
- Announcement on Approval of the Restructuring Plan for the Company and Its Subsidiaries by Court Ruling
- Announcement on Convening and Voting Results of the Creditors' Meeting Related to the Reorganization of the Company and Its Subsidiaries
- Report for Q3 2025
- Announcement on Convening the 3rd Creditors' Meeting for the Restructuring of Holding Subsidiary NINGXIA ZHONGKE BIOLOGICAL NEW MATERIALS CO., LTD.
- Announcement on Court Permission for Wholly-owned Subsidiary Ningxia Xiri Hengli International Trade Co., Ltd. to Continue Business Operations During Reorganization
Later from Ningxia Zhongke Biotechnology
- Indicative Announcement on Change in Equity of Shareholders and Proposed Change of Controlling Shareholder and Actual Controller
- Indicative Announcement on the Risk of Potential Significant Downward Adjustment of the Company’s Stock Price Due to Ex-Rights
- Announcement on the Implementation of Capital Reserve Conversion into Share Capital under the Restructuring Plan
- Indicative Announcement on the Ex-Rights Matters of Capital Reserve Conversion into Share Capital under the Restructuring Plan
- Announcement on Receiving the Full Restructuring Investment from the Restructuring Investor
Follow Ningxia Zhongke Biotechnology into a list and get an email when it puts out news.
Follow Ningxia Zhongke Biotechnology